← Back to all trials
Recruiting
NCT07275827
Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection
Conditions: HELICOBACTER PYLORI INFECTIONS
Sex: All
Ages: 19 Years – N/A
Healthy volunteers: No
Phase: PHASE3
Enrollment: 88
Sponsor: Tanta University
Location: National Liver Institute Shibīn al Kawm
Summary
this Study Evaluating Safety and Effectiveness of (Proton Pump Inhibitor versus Vonoprazan) Based Triple Therapy with or without Zinc to Eradicate H. pylori Infection
Eligibility Criteria
Inclusion Criteria:
* Age \> 18.
* Both males and females.
* Patients who are positive for H.pylori infection by non-invasive Stool Antigen Test (SAT).
Exclusion Criteria:
* Prior H. pylori treatment: Previous treatment for H. pylori infection.
* Allergies: Known allergies to study medications or components.
* Patients cannot finish treatment course.
* Pregnant and Lactating Women.
* Patients with Kidney disease and eGFR \< 30ml/min.
* Patients with Liver disease with Child-Pugh B or C.
Source: ClinicalTrials.gov (NCT07275827). StuddyBuddy aggregates publicly available trial information.
